Cheryl D Coon1, Karon F Cook2. 1. Outcometrix, PO Box 890, Essex, MA, 01929, USA. ccoon@outcometrix.com. 2. Northwestern University, Chicago, IL, USA.
Abstract
PURPOSE: Clinical outcome assessments (COAs) require evidence not only of reliability, validity, and ability to detect change, but also a definition of what constitutes a meaningful change on the instrument. The responder definition specifies the amount of change on the COA that may be interpreted as a treatment benefit and is critical for interpreting what constitutes a meaningful change on the COA scores. However, the literature that describes methods for developing and applying responder definitions can be difficult to navigate. Clear and concise guidelines regarding which methods to apply under what circumstances and how to interpret the results are lacking. This article provides a guide to the variety of available methods and issues that should be considered when establishing responder definitions for interpreting meaningful changes in COA scores. METHODS: An overview is provided for selecting anchors, developing study designs, planning psychometric analyses, using psychometric results to set responder thresholds, and applying responder thresholds in demonstrating treatment efficacy. RESULTS: There are a variety of anchor-based methods for consideration, but they all rely on a preference for strongly related and easily interpretable anchors. The benefits of applying multiple anchors and multiple analytic methods are discussed. The process of triangulation can synthesize results across multiple sources to gain confidence in a proposed responder definition. Though a link to meaningfulness from the patient's perspective is absent, distribution-based methods provide lower bound estimates of score precision and have a role in triangulation. Responder definitions are typically required within regulatory review, but their application may differ across clinical trial programs. CONCLUSIONS: By careful planning of anchor selection, study design, and psychometric methods, COA researchers can establish defensible responder thresholds that ultimately aid patients and clinicians in making informed treatment decisions.
PURPOSE: Clinical outcome assessments (COAs) require evidence not only of reliability, validity, and ability to detect change, but also a definition of what constitutes a meaningful change on the instrument. The responder definition specifies the amount of change on the COA that may be interpreted as a treatment benefit and is critical for interpreting what constitutes a meaningful change on the COA scores. However, the literature that describes methods for developing and applying responder definitions can be difficult to navigate. Clear and concise guidelines regarding which methods to apply under what circumstances and how to interpret the results are lacking. This article provides a guide to the variety of available methods and issues that should be considered when establishing responder definitions for interpreting meaningful changes in COA scores. METHODS: An overview is provided for selecting anchors, developing study designs, planning psychometric analyses, using psychometric results to set responder thresholds, and applying responder thresholds in demonstrating treatment efficacy. RESULTS: There are a variety of anchor-based methods for consideration, but they all rely on a preference for strongly related and easily interpretable anchors. The benefits of applying multiple anchors and multiple analytic methods are discussed. The process of triangulation can synthesize results across multiple sources to gain confidence in a proposed responder definition. Though a link to meaningfulness from the patient's perspective is absent, distribution-based methods provide lower bound estimates of score precision and have a role in triangulation. Responder definitions are typically required within regulatory review, but their application may differ across clinical trial programs. CONCLUSIONS: By careful planning of anchor selection, study design, and psychometric methods, COA researchers can establish defensible responder thresholds that ultimately aid patients and clinicians in making informed treatment decisions.
Authors: Kathleen W Wyrwich; Monika Bullinger; Neil Aaronson; Ron D Hays; Donald L Patrick; Tara Symonds Journal: Qual Life Res Date: 2005-03 Impact factor: 4.147
Authors: Christoph Gerlinger; Ulrike Schumacher; Thomas Faustmann; Antje Colligs; Heinz Schmitz; Christian Seitz Journal: Health Qual Life Outcomes Date: 2010-11-24 Impact factor: 3.186
Authors: Annabel Nixon; Helen Doll; Cicely Kerr; Russel Burge; April N Naegeli Journal: Health Qual Life Outcomes Date: 2016-02-19 Impact factor: 3.186
Authors: Nan E Rothrock; Karon F Cook; Mary O'Connor; David Cella; Ashley Wilder Smith; Susan E Yount Journal: Qual Life Res Date: 2019-08-13 Impact factor: 4.147
Authors: Deborah A Jehu; Jennifer C Davis; Kenneth Madden; Naaz Parmar; Teresa Liu-Ambrose Journal: Qual Life Res Date: 2022-08-23 Impact factor: 3.440
Authors: Christina Wang; Alisa J Stephens-Shields; Leonard R DeRogatis; Glenn R Cunningham; Ronald S Swerdloff; Peter Preston; David Cella; Peter J Snyder; Thomas M Gill; Shalender Bhasin; Alvin M Matsumoto; Raymond C Rosen Journal: J Sex Med Date: 2018-07 Impact factor: 3.802
Authors: Ron D Hays; Karen L Spritzer; Cathy D Sherbourne; Gery W Ryan; Ian D Coulter Journal: Spine (Phila Pa 1976) Date: 2019-05-01 Impact factor: 3.241
Authors: Surinder S Birring; Donald M Bushnell; Michael Baldwin; Heiko Mueller; Natalia Male; Klaus B Rohr; Yoshikazu Inoue Journal: Eur Respir J Date: 2022-06-02 Impact factor: 33.795